根据气流限制水平吸入乌莫替尼/维兰特罗治疗COPD的疗效和安全性:事后分析

{"title":"根据气流限制水平吸入乌莫替尼/维兰特罗治疗COPD的疗效和安全性:事后分析","authors":"M. Asmus, L. Tombs, Riju Ray, I. Naya, I. Boucot","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"15 7-8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Inhaled Umeclidinium/Vilanterol in COPD According to Level of Airflow Limitation: A Post Hoc Analysis\",\"authors\":\"M. Asmus, L. Tombs, Riju Ray, I. Naya, I. Boucot\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":311626,\"journal\":{\"name\":\"B45. COPD: TREATMENT\",\"volume\":\"15 7-8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B45. COPD: TREATMENT\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B45. COPD: TREATMENT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}